META Pharmaceuticals Inc.
PrivateLast Round
Series A
Extension
Dec 1, 2024
Total Funding Raised
$21.1M
Company Overview
META Pharmaceuticals Inc. is a biopharmaceutical company that develops first-in-class small molecule drugs targeting immunometabolism for the treatment of autoimmune and metabolic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
META Pharmaceuticals Inc. Comparables
Compare META Pharmaceuticals Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sitryx | 82% | |
| NImmune Biopharma | 78% | |
| Inapill | 77% | |
META Pharmaceuticals Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Dec 1, 2024 | ||||
| Series A | Mar 1, 2022 | ||||
| Seed | Sep 1, 2021 |
META Pharmaceuticals Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Tiantu Capital | Series A, Seed |
| IMO Ventures | Series A Extension, Series A, Seed |
META Pharmaceuticals Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about META Pharmaceuticals Inc.'s valuation, stock price, and market status.